Medi-Caps (523144.BO) Stock Price
Medi-Caps Price
Revenue at Medi-Caps has contracted by 2.7% per year over the past 19 years to 123.96 M INR. Earnings per share have declined at 9.2% per year over the last 16 years. Medi-Caps's net margin stands at -24.5%, down from 14.4% several years earlier. Medi-Caps currently offers a dividend yield of about 1.53%. The payout ratio is around 20% of earnings.
Medi-Caps stock price
Medi-Caps business model & stock analysis
Frequently asked questions about Medi-Caps
Converted at the current exchange rate, the Medi-Caps share trades at 0.23 EUR (24.53 INR).
The revenue of Medi-Caps is 123.96 M INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Medi-Caps is -30.38 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medi-Caps is currently -10.07. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medi-Caps stock.
The price-to-sales ratio (P/S) of Medi-Caps is currently 2.47. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medi-Caps stock.
The Eulerpool Quality Score for Medi-Caps is 1/10.
The ISIN of Medi-Caps is INE442D01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medi-Caps is 523144.BO. The ticker symbol is used to trade Medi-Caps shares on the stock exchange.
Medi-Caps stock
Medi-Caps Peer Group
Medi-Caps FIGI
All fundamentals and in-depth analysis of Medi-Caps
Our stock analysis for Medi-Caps stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medi-Caps. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.